Healthcare group, Stirling Products Limited (ASX:STI) advises:
TELEMEDCARE (TMC) is fast emerging as a leader in the imminent massive global telehealth market for delivering sophisticated health management in multi-user clinical and community settings, as well as for medications management systems in residential care facilities. Currently, TeleMedCare provides the only viable multi-user vital signs monitoring service/device in the world and is attracting interest from a number of major corporations.
The Company at present is negotiating rights for use in the USA, Canada, Sweden, Russia and India and expects these and potentially others to realize during the course of the year. The Company advises that lead times for such transactions are generally around six months.
For further information please download PDF below: